Phosphotyrosine interactome of the ErbB‐receptor kinase family

Schulze, Waltraud X, Deng, Lei, Mann, Matthias·2005·Molecular Systems Biology
DOI 10.1038/msb4100012

Cited by (754)

Items 701–754 of 754

  1. Analysis of the Efficacy and Cytotoxicity of a Synthesized Anti-HER2 Antibody-Drug Conjugate
    Brody J. Blackburn · 2020 · UA Campus Repository (The University of Arizona)
  2. Integrating Multiplex SiMPull and Computational Modeling to Evaluate Combinatorial Aspects of EGFR Signaling
    Emanuel Salazar-Cavazos, Carolina Franco Nitta, Eshan D. Mitra, Bridget Smith Wilson, Keith A. Lidke, William S. Hlavacek, Diane S. Lidke · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
    Zeba Mueed, Pankaj Kumar Rai, Seemab Siddique, Nitesh Kumar Poddar · 2021 · Current Chemical Biology
  4. Molecular Basis for Phosphate Signaling by Prokaryotic and Eukaryotic Phosphatases
    David Critton · 2011
  5. Characterisation of Metalloprotease-mediated EGFR Signal Transactivation after GPCR Stimulation
    Matthias Schneider · 2011 · Max Planck Institute for Plasma Physics
  6. Cancer Therapeutics in Drosophila melanogaster: A Closer Look at the ErbB Family of Receptor Tyrosine Kinases
    Cassandra J. Buck · 2007 · Digital WPI
  7. Epidermal growth factor receptor family activation and intracellular signaling
    Judy M. Richman · 2008
  8. Clathrin and TOM1L1 regulate epidermal growth factor receptor signaling at the plasma membrane
    Gurjeet Singh Judge · 2021
  9. Faculty Opinions recommendation of Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding.
    Ron Prywes · 2011 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  10. Molecular and biochemical analysis of calreticulin in Solanun lycopersicum
    Fatme Lezzeik · 2013
  11. Clathrin and TOM1L1 regulate epidermal growth factor receptor signaling at the plasma membrane
    Gurjeet Singh Judge · 2021
  12. Programmatic Building of a Secretory Acinus is Driven by Neuronal-Epithelial NRG1-ERBB3-mTORC2 Signaling
    Alison J. May, Aaron J. Mattingly, Eliza A. Gaylord, Noel Cruz‐Pacheco, Elaine Emmerson, Sonia Sudiwala, Seayar Mohabbat, Sara Nathan, Hanan Sinada, Isabelle M. A. Lombaert et al. · 2022 · SSRN Electronic Journal
  13. Activity-based tyrosine phosphatomics using F 2 Pmp probes
    Tomoya Niinae, Yasushi Ishihama · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Data from SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor
    Cheng-Yao Chiang, Chin‐Chen Pan, Hong‐Yi Chang, Ming‐Derg Lai, Tzong‐Shin Tzai, Yuh‐Shyan Tsai, Pin Ling, Hsiao‐Sheng Liu, Bi‐Fang Lee, Hong-Ling Cheng et al. · 2023
  15. Supplementary Methods, Tables 1-6, Figures 1-5 from Signal Transduction Networks in Cancer: Quantitative Parameters Influence Network Topology
    David J. Klinke · 2023
  16. Data from HER3 Is a Determinant for Poor Prognosis in Melanoma
    Markus Reschke, Daniela Mihic‐Probst, Edward Htun van der Horst, Pjotr G. Knyazev, Peter Johannes Wild, Markus Hutterer, Stefanie Meyer, Reinhard Dummer, Holger Moch, Axel Ullrich · 2023
  17. Data from SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor
    Cheng-Yao Chiang, Chin‐Chen Pan, Hong‐Yi Chang, Ming‐Derg Lai, Tzong‐Shin Tzai, Yuh‐Shyan Tsai, Pin Ling, Hsiao‐Sheng Liu, Bi‐Fang Lee, Hong-Ling Cheng et al. · 2023
  18. Supplementary Methods, Tables 1-6, Figures 1-5 from Signal Transduction Networks in Cancer: Quantitative Parameters Influence Network Topology
    David J. Klinke · 2023
  19. Epidermal growth factor receptor: a key manipulator in molecular pathways of malignant glioma
    Changshu Ke · 2016 · Oncology and Translational Medicine
  20. Spatiotemporal Proteomics Deciphers Functional Selectivity of EGFR ligands
    Akihiro Eguchi, Kristina Bennet Emdal, Zilu Ye, Ulises H. Guzmán, Jesper Velgaard Olsen · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Revisiting RAS - Another Tough Nut That's Being Cracked by Cancer Research
    Subhrojyoti Ghosh, Anuvab Dey, Tiyasa Bhuniya, Aritra Paul, Subhranil Hazra, Deb Duhita Mondal, Atharva Anand Mahajan · 2023 · SSRN Electronic Journal
  22. Natural variation in yeast reveals multiple paths for acquiring higher stress resistance
    Amanda N. Scholes, Tara N. Stuecker, Stephanie E. Hood, Cader J. Locke, Carson Stacy, Qingyang Zhang, Jeffrey A. Lewis · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Non-equilibrium strategies enabling ligand specificity by signaling receptors
    Andrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, Purushottam D. Dixit · 2025 · eLife
  24. Implications of gen(om)e duplications on the expansion and evolution of the GPCR signalling pathway
    Ana M. C. Barradas, Waldan K. Kwong · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Discovery and characterization of dynamic modifications of membrane receptor protein machinery
    Yicheng Weng, Jiangnan Zheng, Ruijun Tian · 2024 · Scientia Sinica Chimica
  26. Non-equilibrium strategies for ligand specificity in signaling networks
    Andrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, Purushottam D. Dixit · 2025 · eLife
  27. Non-equilibrium strategies enabling ligand specificity by signaling receptors
    Andrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, Purushottam D. Dixit · 2025 · eLife
  28. Non-equilibrium strategies enabling ligand specificity by signaling receptors
    Andrew Goetz, Jeremy Barrios, Ralitsa Radostinova Madsen, Purushottam D. Dixit · 2025 · eLife
  29. HER Receptor, Current, and Emerging Therapeutic Targets
    Mei Lan Tan, Jia Wen Yeap, Azlinah Matawali · 2025 · Springer eBooks
  30. Computational modeling of protein kinases: Molecular basis for inhibition and catalysis
    Yingting Liu · 2010 · ScholarlyCommons (University of Pennsylvania)
  31. Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapy
    Moulay A. Alaoui‐Jamali, Devanand M. Pinto · 2007 · Humana Press eBooks
  32. Els receptors ErbB en la resposta a l’estimulació adrenèrgica crònica en el ratolí
    Genís Campreciós Figueras · 2010 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  33. Does loss of PRH alter the sensitivity of Dasatinib in breast tumour cells
    ندا کیانی ماوی · 2015 · University of Birmingham Institutional Research Archive (University of Birmingham)
  34. Additional file 1 of SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line
    Filippo Di Pisa, Pesenti, Elisa, Maria Bono, Andrea Nicola Mazzarello, Cinzia Bernardi, Michael P. Lisanti, Giovanni Renzone, Andrea Scaloni, Ermanno Ciccone, Franco Fais et al. · 2021 · Figshare
  35. Additional file 3 of Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling
    Jie Jia, Lianhui Zhu, Xihua Yue, Shuocheng Tang, Shuaiyang Jing, Chuanting Tan, Yulei Du, Jingkai Gao, Intaek Lee, Yi Qian · 2024 · Figshare
  36. Additional file 4 of Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling
    Jie Jia, Lianhui Zhu, Xihua Yue, Shuocheng Tang, Shuaiyang Jing, Chuanting Tan, Yulei Du, Jingkai Gao, Intaek Lee, Yi Qian · 2024 · Figshare
  37. Additional file 1 of SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane
    Li, Hui, Mingming Zhang, Wei, Yanli, Farhan Haider, Lin, Yitong, Guan, Wen, Liu, Yanbin, Zhang, Shaoyang, Ronghua Yuan, Yang, Xia et al. · 2020 · Figshare
  38. Additional file 2 of Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling
    Jie Jia, Lianhui Zhu, Xihua Yue, Shuocheng Tang, Shuaiyang Jing, Chuanting Tan, Yulei Du, Jingkai Gao, Intaek Lee, Yi Qian · 2024 · Figshare
  39. Additional file 1 of Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling
    Jie Jia, Lianhui Zhu, Xihua Yue, Shuocheng Tang, Shuaiyang Jing, Chuanting Tan, Yulei Du, Jingkai Gao, Intaek Lee, Yi Qian · 2024 · Figshare
  40. Additional file 5 of Crosstalk between KDEL receptor and EGF receptor mediates cell proliferation and migration via STAT3 signaling
    Jie Jia, Lianhui Zhu, Xihua Yue, Shuocheng Tang, Shuaiyang Jing, Chuanting Tan, Yulei Du, Jingkai Gao, Intaek Lee, Yi Qian · 2024 · Figshare
  41. The multifaceted roles and diagnostic-therapeutic potential of LINC01410 in malignant tumors and non-malignant disorders
    Kui Zhong, Qiang Yi, Xinting Ouyang, Weijian Zhu, Zheng Chen, Xinlin Wang, Yangneng Zeng, Jianing Zhong, Jinghua Zhong · 2025 · Frontiers in Immunology
  42. Ciblage tumoral du récepteur HER3 à l’aide d’anticorps : vers de nouvelles pistes thérapeutiques
    Yassamine Lazrek · 2013
  43. Ciblage de l'entité HER2/HER3 par des anticorps monoclonaux pour le traitement des cancers du pancréas exprimant faiblement HER2.
    Gaëlle Thomas · 2013
  44. Contrôle de la progression tumorale broncho-pulmonaire par FHIT : Implication du récepteur HER2
    Amina Jouida · 2017
  45. Effets du cisplatine sur la sensibilité des cancers bronchiques non à petites cellules EGFR sauvage aux inhibiteurs de tyrosine kinase anti EGFR
    Judith Raimbourg · 2018
  46. Structural and functional investigation of the C-terminal intrinsically disordered fragment of ErbB2
    Louise Pinet · 2019 · theses.fr (ABES)
  47. Nouveaux mécanismes de régulation de HER2 dans les cancers HER2 positifs : vers de nouvelles approches thérapeutiques
    Lucas Blasquez · 2024
  48. Damnacanthal Suppresses Breast Cancer Cells by Inducing Apoptosis and Cell Cycle Arrest via NF ‐ ĸB Signaling
    Onnichar Jongcharoen, Somrudee Reabroi, Pimtip Sanvarinda, Duangjai Tungmunnithum, Warisara Parichatikanond, Darawan Pinthong · 2026 · Pharmacology Research & Perspectives
  49. The epidermal growth factor (EGF) receptor family network in cardiac hypertrophy and heart failure
    Stephen J. Fuller, Susanna T.E. Cooper, Joshua J. Cull, Nikola ADAMCZYK, Charlotte Tapsell, Riley Pokora, John Spilletts, Philip Richard Dash, Peter H. Sugden, Angela Clerk · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Suppression of EGFR signaling and drug-induced potentiation are widespread features of oncogenic RTK fusions
    Yuzhi Gao, David Gonzalez-Martinez, Sofia Wissert, Hana Bader, Nidhi Sahni, Anh T. Le, Robert Charles Doebele, Lukasz J. Bugaj · 2026 · Proceedings of the National Academy of Sciences
  51. Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma
    Oliver Oakley, Umair Mahmood, Yusuf Ahmad, Elizabeth Smyth · 2026 · Pharmaceuticals
  52. Immunohistochemical evaluation of human epidermal growth factor receptor 2 expression in salivary gland malignancies
    K. Barath Raj, Lloyd A. I. Joseph, B. Premalatha, K. Ramadoss, Veeran Veeravarmal, S. Amuthan · 2026 · Journal of Oral and Maxillofacial Pathology
  53. BindingDB Entry 50021781: Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer.
    BindingDB · 2025 · UC San Diego
  54. BindingDB Entry 50043204: TBA
    BindingDB · 2014 · UC San Diego